• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床及超声特征对婴儿肝血管瘤诊断的价值:与增强CT/MRI的比较

The value of clinical and ultrasound features for the diagnosis of infantile hepatic hemangioma: Comparison with contrast-enhanced CT/MRI.

作者信息

Xu Ming, Pan Fu-Shun, Wang Wei, Zhang Xiao-Er, Li Xiao-Ju, Hong Yu, Zhou Lu-Yao, Xie Xiao-Yan, Lyu Ming-de

机构信息

Department of Medical Ultrasonics, the First Affiliated Hospital, Institute of Diagnostic and Interventional Ultrasound, Sun Yat-Sen University, Guangzhou, China; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Department of Medical Ultrasonics, the First Affiliated Hospital, Institute of Diagnostic and Interventional Ultrasound, Sun Yat-Sen University, Guangzhou, China.

出版信息

Clin Imaging. 2018 Sep-Oct;51:311-317. doi: 10.1016/j.clinimag.2018.06.017. Epub 2018 Jun 21.

DOI:10.1016/j.clinimag.2018.06.017
PMID:29957348
Abstract

OBJECTIVES

To investigate the combined use of ultrasound together with clinical features to differentiate infantile hepatic hemangioma (IHH) from other focal liver lesions (FLLs) in children and to compare the efficacy of the combined method to that of CECT/MRI.

METHODS

The location, number, size and appearance of the tumors were evaluated in 45 children with IHH. Another 45 children with FLL were randomly selected as a control group. Independent factors for predicting IHH versus FLLs were evaluated. The diagnostic performance of the clinical and ultrasound features was compared with CECT/MRI.

RESULTS

Compared with the control FLL group, the IHH group had a younger age at diagnosis (P = 0.008), lower alpha-fetoprotein (AFP) levels (P = 0.000), smaller lesion sizes (P = 0.000), and a higher tumor proportion with a resistance index (RI) of <0.7. Multiple logistic regression analysis showed that age, size, RI and AFP were independent factors for predicting IHH. Receiver operating characteristic (ROC) curve analysis showed that the AUC (area under the curve) of the four combined independent factors was 0.881 (95% CI: 0.744-0.960), while the AUC for the CECT/MRI method was 0.905 (95% CI: 0.774-0.973), and the combined AUC for the independent factors and CECT/MRI was 0.929 (95% CI: 0.805-0.985). There were not statistically significant among the three AUCs (P > 0.05).

CONCLUSIONS

CECT/MRI was the effective diagnostic indicator for IHH. However, the combined clinical and ultrasound diagnoses, including age at diagnosis, lesion size, RI and AFP, can achieve the same effectiveness as CECT/MRI.

摘要

目的

探讨超声联合临床特征鉴别儿童肝内婴儿型血管瘤(IHH)与其他肝脏局灶性病变(FLLs)的价值,并比较该联合方法与CT增强扫描/磁共振成像(CECT/MRI)的诊断效能。

方法

对45例IHH患儿的肿瘤位置、数量、大小及形态进行评估。另随机选取45例FLL患儿作为对照组。评估预测IHH与FLLs的独立因素。将临床及超声特征的诊断效能与CECT/MRI进行比较。

结果

与对照组FLL相比,IHH组诊断时年龄更小(P = 0.008),甲胎蛋白(AFP)水平更低(P = 0.000),病变更小(P = 0.000),阻力指数(RI)<0.7的肿瘤比例更高。多因素logistic回归分析显示,年龄、大小、RI及AFP是预测IHH的独立因素。受试者工作特征(ROC)曲线分析显示,4个联合独立因素的曲线下面积(AUC)为0.881(95%CI:0.744 - 0.960),而CECT/MRI方法的AUC为0.905(95%CI:0.774 - 0.973),独立因素与CECT/MRI联合的AUC为0.929(95%CI:0.805 - 0.985)。三者AUC差异无统计学意义(P>0.05)。

结论

CECT/MRI是IHH的有效诊断指标。然而,临床与超声联合诊断,包括诊断时年龄、病变大小、RI及AFP,可达到与CECT/MRI相同的诊断效能。

相似文献

1
The value of clinical and ultrasound features for the diagnosis of infantile hepatic hemangioma: Comparison with contrast-enhanced CT/MRI.临床及超声特征对婴儿肝血管瘤诊断的价值:与增强CT/MRI的比较
Clin Imaging. 2018 Sep-Oct;51:311-317. doi: 10.1016/j.clinimag.2018.06.017. Epub 2018 Jun 21.
2
Comparative diagnostic value of contrast-enhanced ultrasonography, computed tomography, and magnetic resonance imaging in diagnosis of hepatic hemangiomas.增强超声、计算机断层扫描和磁共振成像对肝血管瘤诊断的比较诊断价值。
Medicina (Kaunas). 2010;46(5):329-35.
3
Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis.声诺维超声增强与对比增强 CT 和对比增强 MRI 对肝脏局灶性病变的诊断价值:荟萃分析。
J Cancer Res Clin Oncol. 2011 Nov;137(11):1595-605. doi: 10.1007/s00432-011-1035-8. Epub 2011 Aug 18.
4
Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.多模态成像评估恶性肝肿瘤患者不可逆电穿孔后的即时反应。
J Med Ultrason (2001). 2017 Jul;44(3):247-254. doi: 10.1007/s10396-016-0767-0. Epub 2016 Dec 8.
5
Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.CEUS 在鉴别诊断直径≤20mm 的小肝脏病变和≤10mm 的亚厘米肝脏病变与组织学的对比中的诊断准确性。DEGUM 多中心试验的结果。
Ultraschall Med. 2011 Dec;32(6):593-7. doi: 10.1055/s-0031-1271114. Epub 2011 Dec 9.
6
Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.超声造影(CEUS)用于肝脏局灶性病变的特征性诊断——临床实践中的前瞻性比较:CEUS与CT(德国超声医学与工程学会多中心试验)。本手稿的部分内容曾在2008年于达沃斯举行的三国超声会议上展示。
Ultraschall Med. 2009 Aug;30(4):383-9. doi: 10.1055/s-0028-1109673. Epub 2009 Aug 17.
7
Infantile Hepatic Hemangioma.
J Pak Med Assoc. 2018 Dec;68(12):1846-1847.
8
Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.多期CT与肝脏特异性对比增强MRI在肝局灶性结节增生鉴别诊断中的效能比较:一项前瞻性队列研究
BMC Gastroenterol. 2018 Jan 15;18(1):10. doi: 10.1186/s12876-017-0719-1.
9
[Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].[使用低机械指数对比增强实时超声和声诺维对肝脏局灶性病变的特征分析]
Rofo. 2003 Jun;175(6):835-43. doi: 10.1055/s-2003-39923.
10
Application of superb microvascular imaging in focal liver lesions.超微血管成像在肝脏局灶性病变中的应用。
World J Gastroenterol. 2017 Nov 21;23(43):7765-7775. doi: 10.3748/wjg.v23.i43.7765.

引用本文的文献

1
Case Report: Hepatic infantile hemangioma malignantly transformed into hemangiosarcoma.病例报告:肝脏婴儿血管瘤恶变为血管肉瘤。
Front Oncol. 2025 Aug 20;15:1614698. doi: 10.3389/fonc.2025.1614698. eCollection 2025.
2
Development and validation of an ultrasound-based interpretable machine learning model for the classification of ≤3 cm hepatocellular carcinoma: a multicentre retrospective diagnostic study.基于超声的≤3cm肝细胞癌分类可解释机器学习模型的开发与验证:一项多中心回顾性诊断研究
EClinicalMedicine. 2025 Feb 13;81:103098. doi: 10.1016/j.eclinm.2025.103098. eCollection 2025 Mar.
3
Accuracy of contrast-enhanced CT in liver neoplasms in children under 2 years age.
2岁以下儿童肝脏肿瘤的增强CT准确性
Pediatr Radiol. 2024 Nov;54(12):1946-1955. doi: 10.1007/s00247-024-05958-w. Epub 2024 Jun 3.
4
Incidental Findings in Pediatric Patients: How to Manage Liver Incidentaloma in Pediatric Patients.儿科患者的偶然发现:如何处理儿科患者的肝脏偶然瘤
Cancers (Basel). 2023 Apr 18;15(8):2360. doi: 10.3390/cancers15082360.
5
Clinical Value Study on Contrast-Enhanced Ultrasound Combined with Enhanced CT in Early Diagnosis of Primary Hepatic Carcinoma.超声造影联合增强 CT 对原发性肝癌早期诊断的临床价值研究。
Contrast Media Mol Imaging. 2022 Sep 2;2022:7130533. doi: 10.1155/2022/7130533. eCollection 2022.
6
Hepatic hemangiomas in childhood: the spectrum of radiologic findings. A pictorial essay.小儿肝脏血管瘤:放射学表现谱。影像学研究论文。
J Ultrasound. 2023 Mar;26(1):261-276. doi: 10.1007/s40477-022-00714-y. Epub 2022 Sep 7.
7
Application value of computer-assisted surgery system in pediatric hepatic hemangioma.计算机辅助手术系统在小儿肝血管瘤中的应用价值。
Pediatr Surg Int. 2021 Nov;37(11):1575-1583. doi: 10.1007/s00383-021-04972-5. Epub 2021 Jul 26.
8
Contrast-enhanced ultrasound of benign and malignant liver lesions in children.儿童肝脏良恶性病变的超声造影。
Pediatr Radiol. 2021 Nov;51(12):2181-2197. doi: 10.1007/s00247-021-04976-2. Epub 2021 May 12.
9
Improving B-mode ultrasound diagnostic performance for focal liver lesions using deep learning: A multicentre study.利用深度学习提高局灶性肝病变的 B 型超声诊断性能:一项多中心研究。
EBioMedicine. 2020 Jun;56:102777. doi: 10.1016/j.ebiom.2020.102777. Epub 2020 Apr 28.
10
APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma.APEX1 是一种新型的肝细胞癌诊断和预后生物标志物。
Aging (Albany NY). 2020 Mar 13;12(5):4573-4591. doi: 10.18632/aging.102913.